133 related articles for article (PubMed ID: 30308939)
1. Hypermethylation of CCND2 in Lung and Breast Cancer Is a Potential Biomarker and Drug Target.
Hung CS; Wang SC; Yen YT; Lee TH; Wen WC; Lin RK
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30308939
[TBL] [Abstract][Full Text] [Related]
2. CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E; Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Blanco-Luquin I; Córdoba A; Vicente-García F; Pérez-Janices N; Escors D; Megías D; López-Serra P; Esteller M; Illarramendi JJ; Guerrero-Setas D
Oncotarget; 2017 Feb; 8(9):15789-15801. PubMed ID: 28178655
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation of the Gene Body in
Shen HT; Hung CS; Davis C; Su CM; Liao LM; Shih HM; Lee KD; Ansar M; Lin RK
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785978
[TBL] [Abstract][Full Text] [Related]
4. E74-like Factor 5 Promoter Methylation in Circulating Tumor DNA as a Potential Prognostic Marker in Breast Cancer Patients.
Salimi M; Rastegarpouyani S
Asian Pac J Cancer Prev; 2023 Dec; 24(12):4035-4041. PubMed ID: 38156835
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Perez-Janices N; Blanco-Luquin I; Torrea N; Liechtenstein T; Escors D; Cordoba A; Vicente-Garcia F; Jauregui I; De La Cruz S; Illarramendi JJ; Coca V; Berdasco M; Kochan G; Ibañez B; Lera JM; Guerrero-Setas D
Oncotarget; 2015 Sep; 6(27):23944-58. PubMed ID: 26284587
[TBL] [Abstract][Full Text] [Related]
6. Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer:
Tian S; Fu L; Zhang J; Xu J; Yuan L; Qin J; Zhang W
Front Immunol; 2021; 12():761326. PubMed ID: 34745136
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 Promoter Hypermethylation in Malignant Breast Tumors and in the Histologically Normal Adjacent Tissues to the Tumors: Exploring Its Potential as a Biomarker and Its Clinical Significance in a Translational Approach.
Oubaddou Y; Oukabli M; Fenniche S; Elktaibi A; Elochi MR; Al Bouzidi A; Qmichou Z; Dakka N; Diorio C; Richter A; Bakri Y; Ameziane El Hassani R
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761820
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the nischarin expression across human tumor types reveals its context-dependent role and a potential as a target for drug repurposing in oncology.
Ostojić M; Đurić A; Živić K; Grahovac J
PLoS One; 2024; 19(5):e0299685. PubMed ID: 38781180
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia.
Elwafa RAHA; Bordiny ME; Salama M; Fawzy A; Omar OM
Pediatr Blood Cancer; 2023 Dec; 70(12):e30678. PubMed ID: 37731174
[TBL] [Abstract][Full Text] [Related]
10. Regulation of mRNA expression in breast cancer - a cis-tematic trans-action.
Verhaak RG; Mills GB
Breast Cancer Res; 2012 Oct; 14(5):322. PubMed ID: 23106814
[TBL] [Abstract][Full Text] [Related]
11. WILMS TUMOR MUTATIONAL SUBCLASSES CONVERGE TO DRIVE
Xu L; Desai K; Kim J; Zhou Q; Guo L; Xiao X; Zhang Y; Zhou L; Yuksel A; Catchpoole DR; Amatruda JF; Chen KS
medRxiv; 2023 Feb; ():. PubMed ID: 36778325
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation biomarkers discovered
Vrba L; Oshiro MM; Kim SS; Garland LL; Placencia C; Mahadevan D; Nelson MA; Futscher BW
Epigenetics; 2020 Apr; 15(4):419-430. PubMed ID: 31775567
[TBL] [Abstract][Full Text] [Related]
13.
Ansar M; Wang CJ; Wang YH; Shen TH; Hung CS; Chang SC; Lin RK
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33036415
[TBL] [Abstract][Full Text] [Related]
14. Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction.
Chang SC; Liew PL; Ansar M; Lin SY; Wang SC; Hung CS; Chen JY; Jain S; Lin RK
Clin Epigenetics; 2020 May; 12(1):67. PubMed ID: 32398064
[TBL] [Abstract][Full Text] [Related]
15. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
16. Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA).
Liang W; Zhao Y; Huang W; Gao Y; Xu W; Tao J; Yang M; Li L; Ping W; Shen H; Fu X; Chen Z; Laird PW; Cai X; Fan JB; He J
Theranostics; 2019; 9(7):2056-2070. PubMed ID: 31037156
[No Abstract] [Full Text] [Related]
17. Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer.
Moss J; Zick A; Grinshpun A; Carmon E; Maoz M; Ochana BL; Abraham O; Arieli O; Germansky L; Meir K; Glaser B; Shemer R; Uziely B; Dor Y
Ann Oncol; 2020 Mar; 31(3):395-403. PubMed ID: 32067681
[TBL] [Abstract][Full Text] [Related]
18. The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.
Park SY; Lee CJ; Choi JH; Kim JH; Kim JW; Kim JY; Nam JS
J Exp Clin Cancer Res; 2019 Sep; 38(1):399. PubMed ID: 31511084
[TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
Magbanua MJM; Swigart LB; Wu HT; Hirst GL; Yau C; Wolf DM; Tin A; Salari R; Shchegrova S; Pawar H; Delson AL; DeMichele A; Liu MC; Chien AJ; Tripathy D; Asare S; Lin CJ; Billings P; Aleshin A; Sethi H; Louie M; Zimmermann B; Esserman LJ; van 't Veer LJ
Ann Oncol; 2021 Feb; 32(2):229-239. PubMed ID: 33232761
[TBL] [Abstract][Full Text] [Related]
20. Association of Circulating Tumor DNA With Disease-Free Survival in Breast Cancer: A Systematic Review and Meta-analysis.
Cullinane C; Fleming C; O'Leary DP; Hassan F; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
JAMA Netw Open; 2020 Nov; 3(11):e2026921. PubMed ID: 33211112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
